Hospital-acquired Infection Control Market Forecast 2023 to 2033 | By Steris, Getinge AB, Ecolab, 3M, Matachana

Future Market Insights recently issued a report on the Hospital-acquired Infection Control Market forecasts, global sales of US$ 6.5 billion in 2023. The Hospital-acquired Infection Control market is predicted to grow at a CAGR of 7% from 2023 to 2033, reaching US$ 12.7 billion by 2033, with hospitals and critical care units expected to generate significant revenue at a CAGR of 7.6%.

The increasing prevalence of Hospital-acquired Infections, the increasing proportion of surgical procedures, the growing geriatric population, the increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are all driving the growth of the Hospital-acquired Infection Control market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16573

The market for Hospital-acquired Infection Control is expected to grow as e-beam sterilisation becomes more popular and ethylene oxide sterilisation is reintroduced.

The growing number of surgical procedures performed worldwide, which presently stands at over 235 million challenging surgeries each year, is increasing demand for surgical equipment and medical devices. Demand for sterile product lines is expected to increase, as is public awareness of their usefulness in healthcare settings.

As a result of rising demand for Hospital-acquired Infection Control methods in developing countries, rising awareness of general health and fitness among the working-class population, and widespread use of Hospital-acquired Infection Controls in the region, the Asia Pacific region, particularly Japan, is expected to grow at a CAGR of more than 7% during the forecast period.

To summarise, the Hospital-acquired Infection Control market is expected to grow rapidly in the coming years, driven by a variety of factors, with each region presenting unique opportunities and difficulties for market participants.

For critical insights on this market, request to ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-16573

Competitive Analysis

The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.

Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:

  • STERIS purchased Cantel, a global producer of infection control products and services, through a U.S. company in 2021 to expand its wide range of sterilising services.
  • Sterigenics S.A.S., a Sotera Health Company subsidiary, plans to increase its European sterilising capacity by expanding ethylene oxide manufacturing in Rantigny, France, in 2021. Getinge introduced the Getinge Solsus 66 steam steriliser for hospitals and surgical equipment in 2020, which has a higher capacity and operating reliability than prior sterilisers.
  • In 2020, Sotera Health Company acquired Iotron, a prominent North American outsourced provider of E-beam sterilisation services. The acquisition was undertaken to help the company expand its electron beam footprint and increase Sterigenics segment revenues.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Hospital-acquired Infection Control Market, presenting historical market data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.

For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/16573

Market Segments Covered in Hospital-acquired Infection Control Industry Analysis

By Component:

  • Equipment
  • Sterilization Equipment
  • Disinfection Equipment
  • Consumables
  • Disinfectants
  • Sterilization Consumables
  • Others (Waste Disposal, PPE)
  • Services

By End-user:

  • Hospitals and Intensive Care Units
  • Ambulatory Surgical and Diagnostic Centers
  • Other End-users

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these